| Disease ID | Disease name | Source of annotation with TCF7L2 | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| 125853 | DIABETES MELLITUS, NONINSULIN-DEPENDENT | ClinVar, OMIM | link to OMIM | 33 | SLC2A2, HNF4A, TCF7L2, SLC30A8, GPD2, PAX4, PTPN1, SLC2A4, ABCC8, HMGA1, LIPC, NEUROD1, CDKAL1, WFS1, PPARG, RETN, AKT2, IRS2, IL6, IRS1, GCGR, CAPN10, IGF2BP2, INSR, PDX1, MTNR1B, GCK, HNF1B, HNF1A, MAPK8IP1, ENPP1, PPP1R3A, KCNJ11 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Basal cell carcinoma | hsa05217 | 6.79 |
| Endometrial cancer | hsa05213 | 6.81 |
| Colorectal cancer | hsa05210 | 6.52 |
| Thyroid cancer | hsa05216 | 7.48 |
| Pathways in cancer | hsa05200 | 3.98 |
| Prostate cancer | hsa05215 | 6.11 |
| Adherens junction | hsa04520 | 6.26 |
| Melanogenesis | hsa04916 | 5.97 |
| Acute myeloid leukemia | hsa05221 | 6.74 |
| Hippo signaling pathway | hsa04390 | 5.37 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | hsa05412 | 6.32 |
| Wnt signaling pathway | hsa04310 | 5.49 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Signaling by Wnt | R-HSA-195721 | 4.79 |
| formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.18 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.64 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.89 |
| Peptide hormone metabolism | R-HSA-2980736 | 6.61 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.66 |
| Ca2+ pathway | R-HSA-4086398 | 7.1 |
| binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 10.18 |
| Metabolism of proteins | R-HSA-392499 | 3.41 |
| deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.59 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.36 |
| Signal Transduction | R-HSA-162582 | 1.78 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.46 |
| TCF7L2 mutants don't bind CTBP | R-HSA-5339700 | 11.4 |
| beta-catenin independent WNT signaling | R-HSA-3858494 | 5.83 |
| Disease | R-HSA-1643685 | 3.33 |
| repression of WNT target genes | R-HSA-4641265 | 9.28 |
| GO term | GO ID | GO IC |
|---|---|---|
| RNA polymerase II regulatory region DNA binding | GO:0001012 | 3.36 |
| core promoter proximal region DNA binding | GO:0001159 | 3.82 |
| binding | GO:0005488 | 0.18 |
| nucleic acid binding | GO:0003676 | 1.44 |
| DNA binding | GO:0003677 | 1.92 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| protein domain specific binding | GO:0019904 | 3.32 |
| repressing transcription factor binding | GO:0070491 | 5.71 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
| core promoter proximal region sequence-specific DNA binding | GO:0000987 | 3.83 |
| transcription regulatory region sequence-specific DNA binding | GO:0000976 | 3.24 |
| double-stranded DNA binding | GO:0003690 | 3.09 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| transcription factor binding | GO:0008134 | 3.46 |
| nuclear hormone receptor binding | GO:0035257 | 4.7 |
| beta-catenin binding | GO:0008013 | 5.3 |
| protein kinase binding | GO:0019901 | 3.44 |
| kinase binding | GO:0019900 | 3.32 |
| enzyme binding | GO:0019899 | 2.27 |
| RNA polymerase II repressing transcription factor binding | GO:0001103 | 6.44 |
| hormone receptor binding | GO:0051427 | 4.57 |
| receptor binding | GO:0005102 | 2.43 |
| RNA polymerase II transcription factor binding | GO:0001085 | 5.08 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| gamma-catenin binding | GO:0045295 | 7.17 |
| armadillo repeat domain binding | GO:0070016 | 7.17 |
| RNA polymerase II regulatory region sequence-specific DNA binding | GO:0000977 | 3.37 |
| protein binding | GO:0005515 | 0.46 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| RNA polymerase II core promoter proximal region sequence-specific DNA binding | GO:0000978 | 3.88 |
| nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |